(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.83%) $83.15
(-1.16%) $1.619
(-0.37%) $2 338.40
(0.82%) $27.48
(0.49%) $926.60
(-0.19%) $0.933
(-0.25%) $11.00
(-0.27%) $0.798
(0.00%) $92.17
Live Chart Being Loaded With Signals
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company...
Stats | |
---|---|
本日の出来高 | 78 817.00 |
平均出来高 | 45 944.00 |
時価総額 | 24.83B |
EPS | $0 ( 2024-02-08 ) |
次の収益日 | ( $0 ) 2024-05-20 |
Last Dividend | $0.141 ( 2021-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 38.60 |
ATR14 | $0.0360 (0.22%) |
ボリューム 相関
Terumo Corporation 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Terumo Corporation 相関 - 通貨/商品
Terumo Corporation 財務諸表
Annual | 2023 |
収益: | $820.21B |
総利益: | $417.37B (50.89 %) |
EPS: | $59.50 |
FY | 2023 |
収益: | $820.21B |
総利益: | $417.37B (50.89 %) |
EPS: | $59.50 |
FY | 2022 |
収益: | $703.30B |
総利益: | $369.34B (52.52 %) |
EPS: | $58.72 |
FY | 2021 |
収益: | $613.84B |
総利益: | $326.62B (53.21 %) |
EPS: | $102.33 |
Financial Reports:
No articles found.
Terumo Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.135 | 2021-03-29 |
Last Dividend | $0.141 | 2021-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $0.277 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.68 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.14 | |
Div. Directional Score | 8.87 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
BHRB | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
PRNDY | Ex Dividend Knight | 2023-06-30 | Semi-Annually | 0 | 0.00% | |
EMSHF | Ex Dividend Knight | 2023-08-15 | Annually | 0 | 0.00% | |
UNCHF | Ex Dividend Knight | 2023-12-28 | Semi-Annually | 0 | 0.00% | |
KIROY | Ex Dividend Knight | 2023-08-17 | Semi-Annually | 0 | 0.00% | |
CCFN | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
SBGSY | Ex Dividend Knight | 2023-05-09 | Annually | 0 | 0.00% | |
FOJCY | Ex Dividend Junior | 2023-09-29 | Annually | 0 | 0.00% | |
AAGIY | Ex Dividend Knight | 2023-09-07 | Annually | 0 | 0.00% | |
WTKWY | Ex Dividend Knight | 2023-08-29 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.112 | 1.500 | 7.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0585 | 1.200 | 8.05 | 9.66 | [0 - 0.3] |
returnOnEquityTTM | 0.0827 | 1.500 | -0.192 | -0.288 | [0.1 - 1] |
payoutRatioTTM | 0.323 | -1.000 | 6.77 | -6.77 | [0 - 1] |
currentRatioTTM | 1.905 | 0.800 | 5.48 | 4.38 | [1 - 3] |
quickRatioTTM | 1.034 | 0.800 | 8.62 | 6.90 | [0.8 - 2.5] |
cashRatioTTM | 0.466 | 1.500 | 8.52 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.134 | -1.500 | 7.77 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 45.48 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 89.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 40.66 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.186 | -1.500 | 9.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.513 | 1.000 | 4.79 | 4.79 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.146 | 1.000 | 9.08 | 9.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.592 | 1.000 | 7.82 | 7.82 | [0.2 - 2] |
assetTurnoverTTM | 0.523 | 0.800 | 9.84 | 7.88 | [0.5 - 2] |
Total Score | 12.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 39.48 | 1.000 | 6.11 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0827 | 2.50 | -0.124 | -0.288 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 40.66 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.00412 | 1.500 | 9.90 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 89.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.323 | 1.500 | 6.77 | -6.77 | [0 - 1] |
pegRatioTTM | 0.188 | 1.500 | -2.08 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.151 | 1.000 | 8.72 | 0 | [0.1 - 0.5] |
Total Score | 5.14 |
Terumo Corporation
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。